OBO_ID (LABEL):	CHEBI_28934 (vitamin D2)

IGNORANCE CATEGORY:	superficial_relationship

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC4600246	10/2015	S15-PMC4600246	['Vitamin K and vascular calcifications\nCoronary Artery calcium (cac) HAS BEEN SHOWN to have increasing prevalence as Kidney function declines.3indeed, cac prevalence HAS BEEN reported in 13% of ‘healthy’ patients without Renal disease,2140% of patients with chronic Kidney disease patients not on dialysis,2157% of patients starting dialysis22and 83% of patients on long-term dialysis.23diets lacking Vitamin K can PRECIPITATE the development of Vitamin K deficiency in as little as 7\u2005days.24additionally, subclinical Vitamin K deficiency is not UNCOMMON, especially in patients receiving warfarin.25cross-sectional and cohort data HAVE SHOWN a lower risk of Coronary Heart disease (chd), chd mortality, all-cause mortality and SEVERE Aortic calcifications with higher Vitamin K2(Menaquinone) intake526(box 1).']	[('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 165), ('SUPERFICIAL_RELATIONSHIP', 414), ('INCOMPLETE_EVIDENCE', 545), ('INCOMPLETE_EVIDENCE', 631), ('IMPORTANT_CONSIDERATION', 727)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin K'), ('UBERON_0001621', 'coronary artery', 38, 'Coronary artery'), ('UBERON_0002113', 'kidney', 116, 'kidney'), ('UBERON_0002113', 'kidney', 220, 'renal'), ('UBERON_0002113', 'kidney', 265, 'kidney'), ('CHEBI_27300', 'vitamin D', 400, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 445, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 517, 'vitamin K'), ('UBERON_0004151', 'cardiac chamber', 658, 'coronary heart'), ('UBERON_0000947', 'aorta', 734, 'aortic'), ('CHEBI_28934', 'vitamin D2', 768, 'vitamin K2'), ('PR_000009450', 'keratin, type II cytoskeletal 1', 776, 'K2'), ('CHEBI_18154', 'polysaccharide', 779, 'menaquinone')]
PMC4600246	10/2015	S47-PMC4600246	['warfarin HAS BEEN SHOWN to prevent the conversion of Vitamin K1To Vitamin K2.40–42since warfarin was stopped prior to the introduction of high-dose Vitamin K1Or K2, it is UNCERTAIN IF EITHER would have PREVENTED these calcifications during concomitant Warfarin administration.']	[('INCOMPLETE_EVIDENCE', 9), ('FULL_UNKNOWN', 171), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 184), ('SUPERFICIAL_RELATIONSHIP', 202)]	5	[('CHEBI_33216', 'bisphenol A', 53, 'vitamin K1to'), ('PR_000017279', 'testis-specific basic protein Y 1', 53, 'vitamin K1to'), ('CHEBI_28934', 'vitamin D2', 66, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 66, 'vitamin K2'), ('CHEBI_31633', 'formoterol fumarate', 148, 'vitamin K1or'), ('PR_000017209', 'utrophin', 148, 'vitamin K1or'), ('PR_000009450', 'keratin, type II cytoskeletal 1', 161, 'K2'), ('CHEBI_10033', 'warfarin', 252, 'warfarin')]
PMC4600246	10/2015	S77-PMC4600246	['finally, in the RECENT vitamin k italian (viki) dialysis STUDY, 23.5% of patients were FOUND to be Vitamin K deficient, and this deficiency was FOUND TO BE the strongest PREDICTOR of vertebral fractures (or: 2.94; 95% ci 1.38 to 6.26).72other data HAVE SHOWN that vitamin K2May improve Bone Remodelling in patients with haemodialysis with low Serum Parathyroid hormone levels.73supplementing with at LEAST 200\u2005µg Menaquinone-7 (a form of Vitamin K2) daily MAY help to achieve near maximal protection from vascular calcification, osteoporosis and cancer (measured by maximal gamma carboxylation of Vitamin K dependent proteins).35\n\nconclusion\nVitamin K has a plethora of POTENTIAL IMPLICATIONS, including prevention and treatment of Arterial calcifications, Coronary Heart disease and cancer, improvements in bone strength and reduced risks of fractures as well as improvements in Insulin sensitivity.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 87), ('ANOMALY_CURIOUS_FINDING', 144), ('SUPERFICIAL_RELATIONSHIP', 170), ('INCOMPLETE_EVIDENCE', 248), ('PROBABLE_UNDERSTANDING', 400), ('INCOMPLETE_EVIDENCE', 456), ('INCOMPLETE_EVIDENCE', 670), ('IMPORTANT_CONSIDERATION', 680)]	10	[('CHEBI_27300', 'vitamin D', 99, 'vitamin K'), ('PR_000009481', 'keratin, type II cytoskeletal 5', 272, 'K2may'), ('GO_0046849', 'bone remodeling', 286, 'bone remodelling'), ('UBERON_0001977', 'blood serum', 343, 'serum'), ('UBERON_0001132', 'parathyroid gland', 349, 'parathyroid'), ('CHEBI_18154', 'polysaccharide', 413, 'menaquinone'), ('CHEBI_28934', 'vitamin D2', 438, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 438, 'vitamin K2'), ('CHEBI_27300', 'vitamin D', 597, 'vitamin K'), ('CHEBI_28384', 'vitamin K', 642, 'Vitamin K'), ('UBERON_0001637', 'artery', 732, 'arterial'), ('UBERON_0004151', 'cardiac chamber', 757, 'coronary heart'), ('PR_000045358', 'insulin family protein', 880, 'insulin')]
PMC5487839	3/2016	S135-PMC5487839	['the Ergocalciferol (Vitamin D2) Metabolite, 25(Oh) D, crosses the Placenta; maternal Serum concentrations CORRELATE with foetal concentrations at Birth.']	[('SUPERFICIAL_RELATIONSHIP', 106)]	1	[('CHEBI_4910', 'etomidate', 4, 'ergocalciferol'), ('CHEBI_28934', 'vitamin D2', 20, 'vitamin D2'), ('PR_000017299', 'VIP peptides', 20, 'vitamin D2'), ('CHEBI_39382', 'flufenoxuron', 32, 'metabolite'), ('CHEBI_71657', 'versiconol acetate', 44, '25(OH) D'), ('PR_000006444', 'diacylglycerol kinase delta', 51, 'D'), ('UBERON_0001987', 'placenta', 66, 'placenta'), ('UBERON_0001977', 'blood serum', 85, 'serum'), ('GO_0007567', 'parturition', 146, 'birth')]
PMC5273824	1/2017	S27-PMC5273824	['RECENTLY, lc-ms/ms became the GOLD STANDARD of measuring Vitamin D level DUE TO its ability to DIFFERENTIATE and ACCURATELY quantify the two subgroups of 25-Oh Vitamin D (25-Oh Vitamin D2 and 25-Oh Vitamin D3); (2) high specificity, which allows DIFFERENTIATION of the target Molecule from other Metabolic intermediates, as well as avoiding INTERFERENCE as SEEN in immunological methods; (3) high sensitivity, which allows detection at ng/ml level.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 30), ('PROBABLE_UNDERSTANDING', 73), ('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 113), ('INCOMPLETE_EVIDENCE', 246), ('PROBLEM_COMPLICATION', 341), ('INCOMPLETE_EVIDENCE', 357)]	8	[('CHEBI_28384', 'vitamin K', 57, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 57, 'Vitamin D'), ('CHEBI_86030', 'O-(hydroxyhexadecanoyl)carnitine', 156, '-OH'), ('CHEBI_28384', 'vitamin K', 160, 'Vitamin D'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 171, '25-OH'), ('CHEBI_28934', 'vitamin D2', 177, 'Vitamin D2'), ('PR_000017279', 'testis-specific basic protein Y 1', 177, 'Vitamin D2'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 192, '25-OH'), ('CHEBI_33237', 'vitamin D4', 198, 'Vitamin D3'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 198, 'Vitamin D3'), ('CHEBI_36357', 'polyatomic entity', 276, 'molecule'), ('GO_0008152', 'metabolic process', 296, 'metabolic')]
PMC5273824	1/2017	S106-PMC5273824	['THEREFORE, Consumption of Vitamin D2-containing supplements is ASSOCIATED with higher Vitamin D2 DETECTION rate among Pregnant women.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 63), ('INCOMPLETE_EVIDENCE', 97)]	3	[('GO_0007631', 'feeding behavior', 11, 'consumption'), ('CHEBI_28934', 'vitamin D2', 26, 'Vitamin D2'), ('PR_000017279', 'testis-specific basic protein Y 1', 26, 'Vitamin D2'), ('CHEBI_28934', 'vitamin D2', 86, 'Vitamin D2'), ('PR_000017279', 'testis-specific basic protein Y 1', 86, 'Vitamin D2'), ('GO_0007565', 'female pregnancy', 118, 'pregnant')]
PMC5273824	1/2017	S111-PMC5273824	['accumulation of Vitamin D2 in Food chain, such as from poultry Fed with Vitamin D2 fortified feeds and their Eggs, also CONTRIBUTE to elevated Vitamin D2 levels in Human bodies.']	[('SUPERFICIAL_RELATIONSHIP', 120)]	1	[('CHEBI_28934', 'vitamin D2', 16, 'Vitamin D2'), ('PR_000017279', 'testis-specific basic protein Y 1', 16, 'Vitamin D2'), ('CHEBI_33290', 'food', 30, 'food'), ('GO_0007631', 'feeding behavior', 63, 'fed'), ('CHEBI_28934', 'vitamin D2', 72, 'Vitamin D2'), ('PR_000017279', 'testis-specific basic protein Y 1', 72, 'Vitamin D2'), ('CL_0000025', 'egg cell', 109, 'eggs'), ('CHEBI_28934', 'vitamin D2', 143, 'Vitamin D2'), ('PR_000017279', 'testis-specific basic protein Y 1', 143, 'Vitamin D2'), ('NCBITaxon_9606', 'Homo sapiens', 164, 'human')]
PMC5941617	5/2018	S445-PMC5941617	['in ibd pediatric patients, 2000\xa0iu/day of Vitamin D3For 6\xa0months was more EFFECTIVE in raising Serum 25(Oh)D concentrations >\u200930\xa0ng/ml than 400 ui/day or doses up to 2000\xa0iu of Vitamin D2[407,408].']	[('SUPERFICIAL_RELATIONSHIP', 74)]	1	[('CHEBI_27364', 'zinc molecular entity', 42, 'vitamin D3for'), ('UBERON_0001977', 'blood serum', 95, 'serum'), ('CHEBI_71657', 'versiconol acetate', 101, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 101, '25(OH ... D'), ('CHEBI_28934', 'vitamin D2', 177, 'vitamin D2'), ('PR_000017299', 'VIP peptides', 177, 'vitamin D2')]
